Andre Goy, MD, discusses the role of CAR-T therapy in lymphomas

preview_player
Показать описание
Dr. Goy, Chairman and Director of the John Theurer Cancer Center (JTCC) at Hackensack University Medical Center and Chief of the Division of Lymphomas, discusses the role of CAR-T therapy in lymphomas
  1. OBRoncology
Рекомендации по теме
Andre Goy, MD, 0:02:05

Andre Goy, MD, discusses the role of CAR-T therapy in lymphomas

Andre Goy, MD, 0:01:38

Andre Goy, MD, discusses how CAR-T therapies are integrated into treatment of large B-Cell lymphoma

Andre Goy, M.D., 0:01:41

Andre Goy, M.D., MS, leads a nationally recognized cancer center

Andre Goy, MD, 0:01:06

Andre Goy, MD, discusses his real-world experience using axi-cel CAR-T cell therapy

Andre Goy, MD, 0:00:53

Andre Goy, MD, discusses the best strategy for using ibrutinib in MCL

Andre Goy, MD, 0:01:29

Andre Goy, MD, discusses the three-year survival analysis of the ZUMA-1 study from ASH 2019

Dr Andre Goy 0:01:52

Dr Andre Goy Discusses Potential Benefits of Earlier Use of CAR T Therapies

Dr Andre Goy 0:00:58

Dr Andre Goy Discusses What We’ve Learned About CAR T Therapies and Cytokine Responses

Andre H. Goy, 0:03:49

Andre H. Goy, MD | 3rd Annual Precision Medicine Symposium: An Illustrated Tumor Board

Dr. Goy Discusses 0:01:00

Dr. Goy Discusses the Cost of CAR T-Cell Therapy

Dr. Goy Discusses 0:01:56

Dr. Goy Discusses Long-Term Follow-Up Results for Ibrutinib in MCL

CALQUENCE® (acalabrutinib) Perspectives: 0:09:28

CALQUENCE® (acalabrutinib) Perspectives: Dr Andre Goy, MD

Andre Goy, MD, 0:01:11

Andre Goy, MD, considers whether off-the-shelf CAR-T cell therapies are becoming a reality

Dr. Andre Goy 0:01:23

Dr. Andre Goy - Find A Doc

Dr. Andre Goy 0:02:54

Dr. Andre Goy - Doximity

Dr. Goy Discusses 0:01:25

Dr. Goy Discusses Challenges in Treatment of MCL

MK-0482-001: evaluating MK-0482 0:01:17

MK-0482-001: evaluating MK-0482 plus pembrolizumab in patients with advanced solid tumors

Dr. Goy on 0:02:11

Dr. Goy on the Significance of Becoming an NCI-Designated Cancer Center

Dr. Goy on 0:02:01

Dr. Goy on Need for Payment Model for CAR T-Cell Therapy

Goy Discusses Impact 0:01:38

Goy Discusses Impact of Roche/Foundation Medicine Partnership on Diagnostics Tech

Andre Goy, MD, 0:01:07

Andre Goy, MD, explains how lenalidomide will impact the management of FL and MZL

Dr. Goy Discusses 0:01:07

Dr. Goy Discusses Combinations in Mantle Cell Lymphoma

Dr. Goy on 0:00:52

Dr. Goy on Future Treatment Approaches in MCL

Dr. Goy on 0:00:57

Dr. Goy on the Results of the FLYER Trial in DLBCL